These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 17054672
21. Precision medicine approaches may be the future for CRLF2 rearranged Down Syndrome Acute Lymphoblastic Leukaemia patients. Page EC, Heatley SL, Yeung DT, Thomas PQ, White DL. Cancer Lett; 2018 Sep 28; 432():69-74. PubMed ID: 29879498 [Abstract] [Full Text] [Related]
22. [Down's syndrome and leukemia]. Bermúdez Cortés M, Verdeguer Miralles A, Jovaní Casano C, Cañete Nieto A, Fernández JM, Ferris Tortajada J, Castel Sánchez V. An Esp Pediatr; 1998 Jun 28; 48(6):593-8. PubMed ID: 9662842 [Abstract] [Full Text] [Related]
23. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group. Puumala SE, Ross JA, Olshan AF, Robison LL, Smith FO, Spector LG. Cancer; 2007 Nov 01; 110(9):2067-74. PubMed ID: 17849462 [Abstract] [Full Text] [Related]
25. Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia. Meissner B, Borkhardt A, Dilloo D, Fuchs D, Friedrich W, Handgretinger R, Peters C, Schrauder A, Schuster FR, Vormoor J, Maecker B, Sykora KW, Zintl F, Welte K, Sauer M. Bone Marrow Transplant; 2007 Nov 01; 40(10):945-9. PubMed ID: 17768387 [Abstract] [Full Text] [Related]
27. Down syndrome and leukemia, an update. Drabkin HA, Erickson P. Prog Clin Biol Res; 1995 Nov 01; 393():169-76. PubMed ID: 8545449 [Abstract] [Full Text] [Related]
28. Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study. Whitlock JA, Sather HN, Gaynon P, Robison LL, Wells RJ, Trigg M, Heerema NA, Bhatia S. Blood; 2005 Dec 15; 106(13):4043-9. PubMed ID: 16109782 [Abstract] [Full Text] [Related]
29. Pharmacokinetics of Chemotherapeutic Drugs in Pediatric Patients With Down Syndrome and Leukemia. Hefti E, Blanco JG. J Pediatr Hematol Oncol; 2016 May 15; 38(4):283-7. PubMed ID: 26907658 [Abstract] [Full Text] [Related]
30. Down syndrome, drug metabolism and chromosome 21. Taub JW, Ge Y. Pediatr Blood Cancer; 2005 Jan 15; 44(1):33-9. PubMed ID: 15390307 [Abstract] [Full Text] [Related]
31. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Zwaan CM, Kaspers GJ, Pieters R, Hählen K, Janka-Schaub GE, van Zantwijk CH, Huismans DR, de Vries E, Rots MG, Peters GJ, Jansen G, Creutzig U, Veerman AJ. Blood; 2002 Jan 01; 99(1):245-51. PubMed ID: 11756178 [Abstract] [Full Text] [Related]
32. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group. Kudo K, Kojima S, Tabuchi K, Yabe H, Tawa A, Imaizumi M, Hanada R, Hamamoto K, Kobayashi R, Morimoto A, Nakayama H, Tsuchida M, Horibe K, Kigasawa H, Tsukimoto I, Japanese Childhood AML Cooperative Study Group. J Clin Oncol; 2007 Dec 01; 25(34):5442-7. PubMed ID: 18048827 [Abstract] [Full Text] [Related]
33. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis. Ariffin H, Garcia JC, Daud SS, Ibrahim K, Aizah N, Ong GB, Chong LA, Mohamad Z. Pediatr Blood Cancer; 2009 Jul 01; 53(1):108-11. PubMed ID: 19260099 [Abstract] [Full Text] [Related]
34. Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors. Brassesco MS, Montaldi AP, Gras DE, Camparoto ML, Martinez-Rossi NM, Scrideli CA, Tone LG, Sakamoto-Hojo ET. Mutagenesis; 2009 Mar 01; 24(2):153-60. PubMed ID: 19028982 [Abstract] [Full Text] [Related]
35. Suspicions regarding the genetic inheritance of acute lymphoblastic leukemia in patients with down syndrome. Behluli E, Nuhii N, Liehr T, Temaj G. J Mother Child; 2022 Mar 01; 26(1):104-110. PubMed ID: 35853737 [Abstract] [Full Text] [Related]
36. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome. Roncadin C, Hitzler J, Downie A, Montour-Proulx I, Alyman C, Cairney E, Spiegler BJ. Pediatr Blood Cancer; 2015 May 01; 62(5):854-8. PubMed ID: 25545182 [Abstract] [Full Text] [Related]
37. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Pui CH, Jeha S. Nat Rev Drug Discov; 2007 Feb 01; 6(2):149-65. PubMed ID: 17268486 [Abstract] [Full Text] [Related]
38. [Acute leukemia in children with Down syndrome: analysis of cases]. Płoszyńska A, Balcerska A, Wierzba J, Brozek J, Chabior M, Bautenbach-Minkowska J, Zaborowska-Sołtys M, Niedźwiecki M, Celińska W. Wiad Lek; 1998 Feb 01; 51 Suppl 4():276-84. PubMed ID: 10731984 [Abstract] [Full Text] [Related]
39. Acute lymphoblastic leukemia in adolescents and young adults in Finland. Usvasalo A, Räty R, Knuutila S, Vettenranta K, Harila-Saari A, Jantunen E, Kauppila M, Koistinen P, Parto K, Riikonen P, Salmi TT, Silvennoinen R, Elonen E, Saarinen-Pihkala UM. Haematologica; 2008 Aug 01; 93(8):1161-8. PubMed ID: 18556413 [Abstract] [Full Text] [Related]
40. Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia. Rabin KR, Smith J, Kozinetz CA. Pediatr Blood Cancer; 2012 Apr 01; 58(4):633-5. PubMed ID: 22106003 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]